Table 1 Prostate and CG volumes evaluated across the different cohorts, C+, C−, 
, 
, 
, 
, 
, 
, and across the two raters.
, 
, 
, 
, 
, 
, and across the two raters.From: Computational imaging reveals shape differences between normal and malignant prostates on MRI
Rater | Volume (ml) ¶ | Total | C1 | C2 | C3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C+ | C− |
|
|
|
|
|
| ||||||
Rater 1 | Prostate | 42.1 ± 18.5 | 60.6 ± 32.0 | 0.01 | 40.1 ± 21.0 | 32.6 ± 14.6 | 0.44 | 41.1 ± 13.4 | 79.5 ± 32.9 | <0.01 | 44.2 ± 20.2 | 69.8 ± 27.9 | 0.01 |
Rater 2 | Prostate | 41.4 ± 18.3 | 60.0 ± 33.4 | 0.01 | 39.2 ± 20.6 | 29.9 ± 12.1 | 0.3 | 40.9 ± 13.6 | 81.5 ± 35.3 | <0.01 | 43.3 ± 20.0 | 69.2 ± 28.1 | <0.01 |
Rater 1 | CG | 17.8 ± 13.2 | 34.4 ± 24.6 | <0.01 | 20.2 ± 17.0 | 16.6 ± 9.5 | 0.95 | 15.9 ± 6.5 | 48.0 ± 29.2 | <0.01 | 17.1 ± 12.4 | 39.2 ± 22.9 | <0.01 |
Rater 2 | CG | 18.0 ± 13.2 | 34.7 ± 26.7 | <0.01 | 20.0 ± 17.1 | 15.2 ± 9.8 | 0.70 | 16.0 ± 6.5 | 50.7 ± 33.9 | <0.01 | 17.8 ± 13.7 | 39.3 ± 22.9 | <0.01 |
